AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (February 26, 2004). doi:10.1152/ajpheart.00946.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/1/H209    most recent
00946.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEVY, B.
Right arrow Articles by LESUR, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEVY, B.
Right arrow Articles by LESUR, O.
Submitted on October 6, 2003
Accepted on February 20, 2004

Comparative effects of vasopressin, norepinephrine and L-Canavanine, a selective inhibitor of inducible nitric oxide synthase in endotoxic shock

Bruno LEVY1, Chantal VALLEE2, Francois LAUZIER2, Gerard PLANTE3, Arnaut MANSARD4, Jean-Pierre MALLIE4, and Olivier LESUR5*

1 Centre de Recherche Clinique CHUS, Groupe de Recherche en Physiopathologie Respiratoire, Sherbrooke, Quebec, Canada; Faculte de Medecine, Laboratoire de Nephrologie Experimentale, Nancy, France
2 Centre de Recherche Clinique CHUS, Groupe de Recherche en Physiopathologie Respiratoire, Sherbrooke, Quebec, Canada
3 Institut de Pharmacologie CHUS, Laboratoire de Physiologie Renale et Vasculaire, Sherbrooke, Quebec, Canada
4 Faculte de Medecine, Laboratoire de Nephrologie Experimentale, Nancy, France
5 Centre de Recherche Clinique CHUS, Groupe de Recherche en Physiopathologie Respiratoire, Sherbrooke, Quebec, Canada; Faculte de Medecine CHUS, Soins Intensifs Medicaux, Sherbrooke, Quebec, Canada

* To whom correspondence should be addressed. E-mail: Olivier.Lesur{at}USherbooke.ca.

Norepinephrine (NE) ; a standard of care, arginine vasopressin (AVP); an alternative candidate, and L-Canavanine (LC); a selective inhibitor of inducible nitric oxide synthase, were compared for efficacy and inocuity on global and regional hemodynamics, plasmatic and tissue lactate/pyruvate ratio (L/P), tissue high energy phosphate, renal function and tissue capillary permeability in a rat model of endotoxic normokinetic shock. Mean arterial pressure (MAP) decreased (~ 35%) but aortic blood flow increased during endotoxin infusion (p<0.05 vs control). Additionally, there was a decrease in mesenteric and renal blood flows along with the regional to systemic ratio (p<0.05 vs control). All tested drugs were able to restore MAP to basal levels whereas they slightly decreased abdominal aortic flow. However, renal and mesenteric flow remained unchanged in experimental groups. Endotoxin significantly decreased diuresis and inulin clearance (~ 3- to 4-fold) whereas AVP or LC attenuated this drop (p<0.05 vs control). In contrast, NE did not improve endotoxin-induced renal dysfunction. Endotoxin induced gut and lung hyperpermeability (p<0.05 vs control). Endotoxininduced gut hyperpermeability was inhibited by AVP, LC and NE. Endotoxin-induced lung hyperpermeability was further worsened by NE (~ 2-fold increase) but not by AVP infusion (p<0.05 vs endotoxin). LC significantly improved endotoxin-induced pulmonary hyperpermeability. Endotoxin increased renal lactate and decreased renal ATP. NE did not change renal lactate and renal ATP. AVP and LC decreased renal lactate and normalized renal ATP. Finally, endotoxin was associated with increased lactate levels and lactate/pyruvate (L/P) ratio (~2- and 1.5-fold increases vs control, respectively), while AVP and LC, instead of NE, normalized both parameters after endotoxin challenge. These results suggest that, in a short-term endotoxic shock model, AVP improves systemic hemodynamics without side effects and has particular beneficial effects on renal function.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
S. L. M. Mitchell and J.M. Hunter
Vasopressin and its antagonists: what are their roles in acute medical care?
Br. J. Anaesth., August 1, 2007; 99(2): 154 - 158.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. A. Munger, R. C. Blantz, and M. J. Lortie
Acute renal response to LPS: impaired arginine production and inducible nitric oxide synthase activity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R684 - R691.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J.-J. Boffa and W. J. Arendshorst
Maintenance of Renal Vascular Reactivity Contributes to Acute Renal Failure during Endotoxemic Shock
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 117 - 124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.